Ring Therapeutics
Cato Prince is a Scientist I at Ring Therapeutics and has previously held positions as Associate Scientist, Senior Research Associate, and Research Associate at the same company. Prior to joining Ring Therapeutics, Cato served as an Intern at UMass Memorial Medical Center. Cato holds a Master's degree in Microbiology from the University of Massachusetts Amherst, along with a Bachelor's degree in Microbiology from the same institution.
Ring Therapeutics
Ring Therapeutics' Anellogy™ platform aims to usher in a new era of gene therapy using the human commensal virome.